BK7508 Pharmaceutical Companies
Closed 02-19 16:00:00 AEDT
622.45
+5.74
+0.93%
High623.50Low614.48Vol39.84M
Open618.94D1 Closing616.71Amplitude1.46%
Mkt Cap0.00Tradable Cap0.00Total Shares0.00
T/O170.24MT/O Rate--Tradable Shares0.00
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

CSL Ltd-Change of Director's Interest Notice
THOMSON REUTERS  ·  11:43
CSL Ltd-Change of Director's Interest Notice
Invion Ltd-Emergence 2026 Investor Presentation
THOMSON REUTERS  ·  06:00
Invion Ltd-Emergence 2026 Investor Presentation
A Look At Botanix Pharmaceuticals (ASX:BOT) Valuation After Its A$45m Follow On Equity Offerings
Simply Wall St.  ·  02-18 12:44
A Look At Botanix Pharmaceuticals (ASX:BOT) Valuation After Its A$45m Follow On Equity Offerings
3 ASX Penny Stocks With Market Caps Under A$600M
Simply Wall St.  ·  02-18 10:05
3 ASX Penny Stocks With Market Caps Under A$600M
Imricor Medical Systems Secures Third Site for Heart Procedure Trial
MT Newswires Live  ·  02-18 09:22
Imricor Medical Systems Secures Third Site for Heart Procedure Trial
BRIEF-Mayne Pharma To Claim Against Cosette, Others
Reuters  ·  02-18 09:15
BRIEF-Mayne Pharma To Claim Against Cosette, Others
BUZZ-Australia's CSL recovers after signing licensing deal with Eli Lilly
Reuters  ·  02-18 08:32
BUZZ-Australia's CSL recovers after signing licensing deal with Eli Lilly
Mayne Pharma - Will Commence Proceedings in Supreme Court of New South Wales Against Cosette, Others
THOMSON REUTERS  ·  02-18 06:35
Mayne Pharma - Will Commence Proceedings in Supreme Court of New South Wales Against Cosette, Others
Mayne Pharma Group Ltd - Seeks Substantial Damages Against Cosette for Breach of Sid, Others
THOMSON REUTERS  ·  02-18 06:35
Mayne Pharma Group Ltd - Seeks Substantial Damages Against Cosette for Breach of Sid, Others
Starpharma H1 Net Income AUD 1.4 Million
THOMSON REUTERS  ·  02-18 05:38
Starpharma H1 Net Income AUD 1.4 Million
BRIEF-CSL And Lilly Enter Licensing Agreement For Clazakizumab
Reuters  ·  02-18 05:19
BRIEF-CSL And Lilly Enter Licensing Agreement For Clazakizumab
CSL Ltd - CSL Will Receive an Upfront Payment of $100 Mln
THOMSON REUTERS  ·  02-18 05:13
CSL Ltd - CSL Will Receive an Upfront Payment of $100 Mln
CSL Ltd - Exclusive Licensing Agreement Granting Certain Rights to Develop and Commercialise Clazakizumab
THOMSON REUTERS  ·  02-18 05:13
CSL Ltd - Exclusive Licensing Agreement Granting Certain Rights to Develop and Commercialise Clazakizumab
Immutep Initiated at Market Outperform by Citizens
Dow Jones  ·  02-17 22:18
Immutep Initiated at Market Outperform by Citizens
Immuron Limited Receives A$1.12 Million R&D Tax Incentive
Reuters  ·  02-17 21:02
Immuron Limited Receives A$1.12 Million R&D Tax Incentive
Botanix Pharmaceuticals to Raise About AU$40 Million via Share Placement; Shares Hit Three-Year Low
MT Newswires Live  ·  02-17 10:37
Botanix Pharmaceuticals to Raise About AU$40 Million via Share Placement; Shares Hit Three-Year Low
BRIEF-Botanix Pharmaceuticals Receives Firm Commitments For A$40 Million Two-Tranche Placement
Reuters  ·  02-17 09:23
BRIEF-Botanix Pharmaceuticals Receives Firm Commitments For A$40 Million Two-Tranche Placement
Botanix Pharmaceuticals Ltd - Firm Commitments for a$40 Mln Two-Tranche Placement at a$0.06 per New Share
THOMSON REUTERS  ·  02-17 06:43
Botanix Pharmaceuticals Ltd - Firm Commitments for a$40 Mln Two-Tranche Placement at a$0.06 per New Share
Assessing NewMarket (NEU) Valuation As Shares Trade Near Half Of DCF Fair Value Estimate
Simply Wall St.  ·  02-17 04:16
Assessing NewMarket (NEU) Valuation As Shares Trade Near Half Of DCF Fair Value Estimate
CSL Limited Receives Australian Approval for Neffy Adrenaline Nasal Spray
Reuters  ·  02-16
CSL Limited Receives Australian Approval for Neffy Adrenaline Nasal Spray

Introduction

Company Name.
BK7508
Affiliated Markets:
Listing Date:
--
Main Business:
Issue price:
--